from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3885c/eccE2

LFCtreatmentdescriptionclass of inhibitor

-0.236

Amikacinug/mL Amikacintranslation

-1.323

Cap5-10ug/mL Capreomycintranslation

-1.320

Rox10-50 ug/mL Roxithromycintranslation

-0.513

SM2-5 ug/mL Streptomycintranslation

-3.321

Tet5-10 ug/mL Tetracyclinetranslation

1.690

Rif0.2-5ug/mL Rifampicintranscription

1.276

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.136

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.709

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.222

CPZ10-50 ug/mL Chlorpromazinerespiration

1.160

Clofazimine10-13 ug/mL Clofaziminerespiration

0.337

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.016

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.250

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.727

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.850

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.059

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.220

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.985

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.456

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.010

KCN5-20 ug/mL Potassium cyaniderespiration

-0.300

NaN30.2-2 mM Sodium aziderespiration

-0.376

Nigericin50 uM Nigericinrespiration

0.284

TRC10-150 ug/mL Triclosanrespiration

0.751

TRZ10-25 ug/mL Thioridazinerespiration

0.003

Valinomycin0.5-10 uM Valinomycinrespiration

-1.500

ZnSO42 mM ZnSO4respiration

-1.114

menadione6-10 ug/mL Menadionerespiration

0.478

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.939

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.135

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.334

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.139

NRP_1Non-replicating persistence stage 1dosRassociated

0.393

Amp0.2mg/mL AmpicillincellWall

0.088

Cephalexin20-100 ug/mL CephalexincellWall

-0.127

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.024

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.176

EMB10-20 ug/mL EthambutolcellWall

-0.321

Eta12-40 ug/mL EthionamidecellWall

-0.422

INH0.2-0.4 ug/mL IsoniazidcellWall

0.428

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.643

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.539

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.330

BZA0.12 mg/mL BenzamidearomaticAmides

0.098

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.194

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.109

H2O24 mM hydrogen peroxideDNAdamaging

0.047

Levo10 ug/mL LevofloxacinDNAdamaging

-0.625

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.254

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.396

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.016

UVUV-irradiationDNAdamaging

1.657

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.130

Antimycin12.5-50 ug/mL Antimycin A?

-0.205

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.490

PA_110-50 ug/mL Antitubercular compound PA-1?

0.338

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.009

PA8240.2-2 ug/mL PA-824?

-0.314

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.574

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.367

Verapamil50 uM Verapamil?

0.073

mercaptoethanol2 mM 2-Mercaptoethanol?

0.193

methoxatin10-20 ug/mL Methoxatin?